In an era defined by volatility, complexity, and rising expectations for resilience and service, visibility has emerged as the critical foundation of a truly end-to-end supply chain. Yet for many pharma organizations, visibility remains fragmented and trapped within functions, systems, or partners, limiting its impact on real decision-making and execution. This keynote panel brings together senior supply chain and operations leaders to explore how they are elevating visibility from a monitoring capability to a strategic enabler of integrated operating models. Panelists will discuss how real-time, shared visibility across planning, manufacturing, and distribution is reshaping how decisions are made, how teams collaborate, and how organizations respond to disruption. The conversation will focus on how leading companies are using visibility to break down silos, align functions, and drive faster, more confident, and more patient-centric outcomes across the value chain.

• Move from fragmented tracking to shared, real-time visibility that supports end-to-end decision-making
• Use visibility to redesign operating models, reduce latency, and improve cross-functional alignment
• Translate visibility into action through clearer governance, accountability, and execution pathways